Endocrine Society GUIDELINES Bundle (free trial)

Hyperglycemia

Endocrine Society GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1483748

Contents of this Issue

Navigation

Page 8 of 9

9 Recommendations 9.1 and 9.2 (cont'd) Remarks: ▶ Patients who perform CC in the outpatient setting, including those with insulin-treated T2D, may prefer to continue this method of calculating prandial insulin doses during hospitalization. An insulin to carbohydrate ratio (ICR) is used to calculate the prandial dose of insulin when using CC. ▶ A policy to guide CC for calculating prandial insulin dosing in the hospital is necessary for safe implementation, as is expertise from a health care professional knowledgeable in diabetes management. ▶ In hospitals where expertise, resources, and training are available, either CC or fixed prandial insulin dosing can be implemented. ▶ Adjustments to the ICR may be needed in the hospital setting to address the impact of illness or treatments on insulin requirements (e.g., glucose-interfering medications, infection, surgery, insulin resistance). Recommendation 10.1 ➤ In adults with no prior history of diabetes hospitalized for non-critical illness with hyperglycemia (defined as BG >140 mg/dL [7.8 mmol/L]) during hospitalization, we suggest initial therapy with correctional insulin over scheduled insulin therapy (defined as usual basal or basal/ bolus) to maintain glucose targets in the range of 100–180 mg/dL (5.6–10.0 mmol/L). For patients with persistent hyperglycemia (≥2 POC-BG measurements ≥180 mg/dL [≥10.0 mmol/L] in a 24-hour period on correctional insulin), we suggest the addition of scheduled insulin therapy. (2|⊕ ) Recommendation 10.2 ➤ In adults with diabetes treated with diet or non-insulin diabetes medications prior to admission, we suggest initial therapy with correctional insulin or scheduled insulin therapy to maintain glucose targets in the range of 100–180 mg/dL (5.6–10.0 mmol/L). For hospitalized adults started on correctional insulin alone and with persistent hyperglycemia (≥2 POC-BG measurements ≥180 mg/dL in a 24-hour period [≥10.0 mmol/L]), we suggest addition of scheduled insulin therapy. We suggest initiation of scheduled insulin therapy for patients with confirmed admission BG >180 mg/dL (≥10.0 mmol/L). (2|⊕ ) Recommendation 10.3 ➤ In adults with insulin-treated diabetes prior to admission who are hospitalized for non-critical illness, we recommend continuation of the scheduled insulin regimen modified for nutritional status and severity of illness to maintain glucose targets in the range of 100–180 mg/dL (5.6–10.0 mmol/L). (1|⊕⊕ ) Remarks: ▶ Reductions in the dose of basal insulin (by 10–20%) at time of hospitalization may be required for patients on basal heavy insulin regimens (defined as doses of basal insulin ≥0.6–1.0 units/kg/day), in which basal insulin is being used inappropriately to cover meal-related excursions in blood glucose.

Articles in this issue

Archives of this issue

view archives of Endocrine Society GUIDELINES Bundle (free trial) - Hyperglycemia